Understanding ‘Spiritual Emergency’ in the Context of Psychedelics

atai Life Sciences Increases Loan in Principal by US$6m to Support...

Small Pharma Announces Engagement of Investor Relations Provider

Fear of Death Impacts Quality of Life-How Psychedelics Can Help

PT262 – Carlene MacMillan, M.D. – Set, Setting, and Systems: Adding...

Wesana Health Commits Funding of $1.5 Million To Support MAPS’ Research...

COMPASS Pathways acquires IP portfolio of novel psychedelic compounds and prodrugs

Perception Neuroscience initiates Phase 2a study of PCN-101 (R-ketamine) for treatment...

Mindset Pharma Further Validates Lead Candidate, MSP-1014, as a Next Generation...

NeonMind Announces Divestiture of Consumer Related and Other Non-Core Assets

Load more